Vedanta Biosciences
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
About Vedanta Biosciences
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Total Funding
- $436,994,519
- Last Funding Type
- grant
- Last Funding Date
- 2024-04-30
- Website
- vedantabio.com
Industries & Categories
Biotechnology, Business Development, Medical
Social Links
Canonical: https://fsome.com/organization/vedanta-biosciences-98760 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.